Group One Trading’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.92K Sell
4,100
-14,400
-78% -$23.2K ﹤0.01% 6679
2026
Q2
$36.1K Sell
18,500
-2,000
-10% -$4.08K ﹤0.01% 5616
2026
Q1
$49.4K Sell
20,500
-15,300
-43% -$34.2K ﹤0.01% 5264
2025
Q4
$71.6K Sell
35,800
-57,700
-62% -$137K ﹤0.01% 5284
2025
Q3
$285K Buy
93,500
+85,700
+1,099% +$267K ﹤0.01% 4273
2025
Q2
$19.7K Buy
+7,800
New +$18.7K ﹤0.01% 6270
2024
Q3
– Sell
-5,100
Closed -$5.2K – 7048
2024
Q2
$5.2K Buy
+5,100
New +$5.24K ﹤0.01% 5931
2024
Q1
– Sell
-39,500
Closed -$64.8K – 7591
2023
Q4
$64.8K Buy
39,500
+38,900
+6,483% +$51.8K ﹤0.01% 4848
2023
Q3
$834 Hold
600
– – ﹤0.01% 7247
2023
Q2
$1.63K Buy
+600
New +$1.2K ﹤0.01% 7143

Other funds holding MBOT

Group One Trading's MBOT Position: Q3 2026 in Review

Group One Trading reduced its Microbot Medical (MBOT) stake by 40% in Q3 2026, selling an estimated $68.8K and leaving 63,764 shares worth $76.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4935.

Group One Trading first reported a position in MBOT in Q2 2023 and has held it in 9 quarters since. The position peaked at $208K in Q2 2026. 61 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Group One Trading held 63,764 shares of Microbot Medical worth $76.5K as of Q3 2026.
  • Group One Trading sold 42,665 Microbot Medical shares in Q3 2026, an estimated $68.8K.
  • Microbot Medical made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4935 holding.
  • Group One Trading first reported a position in Microbot Medical in Q2 2023 and has held it in 9 quarters since.
  • Group One Trading's Microbot Medical position peaked at $208K in Q2 2026.
  • 61 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.